Rano Amirkhanovna Zhankina
Research Subjects
Rano Amirkhanovna Zhankina has a total of 28 co-authors. Here are the top co-authors by number of shared publications:
Nader Tanideh
Department of Pharmacology, Shiraz University of Medical Sciences, Shiraz, Iran
6 shared publicationsUlanbek Zhanbyrbekuly
Department of Urology and Andrology, NC JSC “Astana Medical University”, Astana, Republic of Kazakhstan
6 shared publicationsAigul Saparbekovna Botabayeva
Department of Urology and Andrology, NC JSC “Astana Medical University”, Astana, Republic of Kazakhstan
5 shared publicationsAigul S. Botabayeva
Department of Urology and Andrology, NC JSC “Astana Medical University”, Astana, Republic of Kazakhstan
1 shared publication- Ali Talyshinskii
Saint Petersburg State University
1 shared publication - Almaz Ibragimov
Department of Urology and Andrology, Astana Medical University, Nur-Sultan, Kazakhstan
1 shared publication
Latest Publications
- 30 August 2026
- Published by Semey Medical University in Наука и здравоохранение
- No. 4(28),p. 263-273
THE ROLE OF VITAMIN «D» IN THE TREATMENT OF CHRONIC RHINOSINUSITIS WITH NASAL POLYPS. LITERATURE REVIEW
Relevance. Chronic rhinosinusitis with nasal polyps (CRSwNP) is a severe inflammatory endotype of chronic rhinosinusitis characterised by persistent Type 2 immune activation, epithelial barrier dysfunction, tissue remodelling, and a high rate of postoperative recurrence despite advances in functional endoscopic sinus surgery (FESS) and biologic therapy. Vitamin D (25-hydroxyvitamin D, 25(OH)D) has emerged as an important immunomodulatory factor involved in sinonasal mucosal homeostasis. Aim. Analysis of current clinical, molecular, and translational data on the role of vitamin D in the pathogenesis of CRSwNP, its therapeutic potential, and its relevance for relapse prevention according to the literature. Search strategy. ublications indexed in PubMed, Scopus, Web of Science, the Cochrane Library, and eLibrary (RSCI) between 2015 and 2025 were reviewed. Fifteen key studies investigating serum 25(OH)D levels, vitamin D receptor (VDR) polymorphisms, and clinically relevant outcomes in CRSwNP were included. Results. Evidence indicates that vitamin D supports mucosal homeostasis by enhancing epithelial barrier integrity through upregulation of tight junction proteins (ZO-1, occludin), inducing antimicrobial peptides such as cathelicidin (LL-37), suppressing Type 2 inflammation, and modulating tissue remodelling pathways. Clinically, vitamin D deficiency (serum 25(OH)D <20 ng/mL) is associated with higher Lund–Mackay CT scores and an increased risk of postoperative polyp recurrence following FESS. In addition, vitamin D may enhance corticosteroid responsiveness and potentially improve the effectiveness of biologic therapy through better control of inflammatory activity. Conclusion. Vitamin D status appears to be an independent predictor of disease severity and recurrence in CRSwNP. Maintaining serum 25(OH)D levels above 30 ng/mL may contribute to epithelial barrier preservation, attenuation of Type 2 inflammation, and reduction of disease recurrence. Routine assessment of vitamin D status and targeted supplementation should be considered within perioperative management strategies for CRSwNP. Актуальность. Хронический риносинусит с полипами носа (CRSwNP) является тяжелым воспалительным эндотипом хронического риносинусита, характеризующимся стойкой иммунной активацией 2-го типа, нарушением функции эпителиального барьера, ремоделированием тканей и высокой частотой послеоперационных рецидивов, несмотря на достижения функциональной эндоскопической хирургии околоносовых пазух (FESS) и биологической терапии. Витамин D рассматривается как важный иммуномодулирующий фактор, участвующий в регуляции воспалительных процессов в слизистой оболочке полости носа и околоносовых пазух. Цель. Анализ современных клинических, молекулярных и трансляционных данных о роли витамина D в патогенезе CRSwNP, его терапевтическом потенциале и его значимости для профилактики рецидивов по данным литературы. Стратегия поиска. Проведен поиск публикаций в базах PubMed, Scopus, Web of Science, Cochrane Library и eLibrary (РИНЦ) за период 2015–2025 гг. Проанализированы 15 ключевых исследований, посвященных уровню сывороточного 25(OH)D, полиморфизмам рецептора витамина D (VDR) и клиническим исходам при CRSwNP. Результаты. Установлено, что витамин D способствует поддержанию гомеостаза слизистой оболочки за счет усиления экспрессии белков плотных контактов (ZO-1, окклюдин), индукции антимикробного пептида кателицидина (LL-37), подавления воспаления 2-го типа и регуляции процессов ремоделирования тканей. Дефицит витамина D (25(OH)D <20 нг/мл) ассоциирован с более высокими показателями по шкале Lund–Mackay и увеличением риска послеоперационного рецидива полипов после FESS до 3,5 раза. Кроме того, витамин D способен повышать чувствительность к кортикостероидам и потенциально усиливать эффективность биологической терапии. Заключение. Статус витамина D может рассматриваться как независимый предиктор тяжести заболевания и риска рецидива при CRSwNP. Поддержание уровня 25(OH)D выше 30 нг/мл может способствовать сохранению целостности эпителиального барьера, снижению выраженности воспаления 2-го типа и уменьшению частоты рецидивов. Целесообразно включение оценки уровня 25(OH)D и его коррекции в комплексное ведение пациентов с CRSwNP. Өзектілігі. Мұрын полиптері бар...
- 30 August 2026
- Published by Semey Medical University in Наука и здравоохранение
- No. 4(28),p. 263-273
THE ROLE OF VITAMIN «D» IN THE TREATMENT OF CHRONIC RHINOSINUSITIS WITH NASAL POLYPS. LITERATURE REVIEW
Relevance. Chronic rhinosinusitis with nasal polyps (CRSwNP) is a severe inflammatory endotype of chronic rhinosinusitis characterised by persistent Type 2 immune activation, epithelial barrier dysfunction, tissue remodelling, and a high rate of postoperative recurrence despite advances in functional endoscopic sinus surgery (FESS) and biologic therapy. Vitamin D (25-hydroxyvitamin D, 25(OH)D) has emerged as an important immunomodulatory factor involved in sinonasal mucosal homeostasis. Aim. Analysis of current clinical, molecular, and translational data on the role of vitamin D in the pathogenesis of CRSwNP, its therapeutic potential, and its relevance for relapse prevention according to the literature. Search strategy. ublications indexed in PubMed, Scopus, Web of Science, the Cochrane Library, and eLibrary (RSCI) between 2015 and 2025 were reviewed. Fifteen key studies investigating serum 25(OH)D levels, vitamin D receptor (VDR) polymorphisms, and clinically relevant outcomes in CRSwNP were included. Results. Evidence indicates that vitamin D supports mucosal homeostasis by enhancing epithelial barrier integrity through upregulation of tight junction proteins (ZO-1, occludin), inducing antimicrobial peptides such as cathelicidin (LL-37), suppressing Type 2 inflammation, and modulating tissue remodelling pathways. Clinically, vitamin D deficiency (serum 25(OH)D <20 ng/mL) is associated with higher Lund–Mackay CT scores and an increased risk of postoperative polyp recurrence following FESS. In addition, vitamin D may enhance corticosteroid responsiveness and potentially improve the effectiveness of biologic therapy through better control of inflammatory activity. Conclusion. Vitamin D status appears to be an independent predictor of disease severity and recurrence in CRSwNP. Maintaining serum 25(OH)D levels above 30 ng/mL may contribute to epithelial barrier preservation, attenuation of Type 2 inflammation, and reduction of disease recurrence. Routine assessment of vitamin D status and targeted supplementation should be considered within perioperative management strategies for CRSwNP. Актуальность. Хронический риносинусит с полипами носа (CRSwNP) является тяжелым воспалительным эндотипом хронического риносинусита, характеризующимся стойкой иммунной активацией 2-го типа, нарушением функции эпителиального барьера, ремоделированием тканей и высокой частотой послеоперационных рецидивов, несмотря на достижения функциональной эндоскопической хирургии околоносовых пазух (FESS) и биологической терапии. Витамин D рассматривается как важный иммуномодулирующий фактор, участвующий в регуляции воспалительных процессов в слизистой оболочке полости носа и околоносовых пазух. Цель. Анализ современных клинических, молекулярных и трансляционных данных о роли витамина D в патогенезе CRSwNP, его терапевтическом потенциале и его значимости для профилактики рецидивов по данным литературы. Стратегия поиска. Проведен поиск публикаций в базах PubMed, Scopus, Web of Science, Cochrane Library и eLibrary (РИНЦ) за период 2015–2025 гг. Проанализированы 15 ключевых исследований, посвященных уровню сывороточного 25(OH)D, полиморфизмам рецептора витамина D (VDR) и клиническим исходам при CRSwNP. Результаты. Установлено, что витамин D способствует поддержанию гомеостаза слизистой оболочки за счет усиления экспрессии белков плотных контактов (ZO-1, окклюдин), индукции антимикробного пептида кателицидина (LL-37), подавления воспаления 2-го типа и регуляции процессов ремоделирования тканей. Дефицит витамина D (25(OH)D <20 нг/мл) ассоциирован с более высокими показателями по шкале Lund–Mackay и увеличением риска послеоперационного рецидива полипов после FESS до 3,5 раза. Кроме того, витамин D способен повышать чувствительность к кортикостероидам и потенциально усиливать эффективность биологической терапии. Заключение. Статус витамина D может рассматриваться как независимый предиктор тяжести заболевания и риска рецидива при CRSwNP. Поддержание уровня 25(OH)D выше 30 нг/мл может способствовать сохранению целостности эпителиального барьера, снижению выраженности воспаления 2-го типа и уменьшению частоты рецидивов. Целесообразно включение оценки уровня 25(OH)D и его коррекции в комплексное ведение пациентов с CRSwNP. Өзектілігі. Мұрын полиптері бар...
- Open Access
- 1 July 2026
- Published by Wolters Kluwer Health in West Kazakhstan Regenerative Medicine Journal
- Vol. 14 (3) , 197-203
Male Infertility in Central Asia: Epidemiology and Risk Factors from a Multicenter Study
A BSTRACT: Male infertility represents a substantial yet undercharacterized component of reproductive health in Central Asia, a region shaped by unique environmental exposures, heterogeneous healthcare systems, and evolving demographic patterns. Importantly, the current evidence base is predominantly derived from the clinic-based populations and should not be interpreted as reflecting population-level prevalence, which remains largely undefined across the region. This mini-review synthesizes the available evidence on the epidemiology and risk factors of male infertility across Kazakhstan, Uzbekistan, Kyrgyzstan, Tajikistan, and Turkmenistan, with a focus on multicenter cross-sectional research frameworks. Among clinic-based cohorts of infertile couples, male-factor infertility rates have been reported to reach up to 52.9%, although these estimates are influenced by care-seeking patterns, referral bias, and diagnostic variability. Environmental and occupational exposures – including particulate air pollution, pesticide residues, and dust–salt aerosols from the Aral Sea – emerge as biologically plausible contributors to impaired spermatogenesis. Lifestyle and metabolic factors such as smoking and obesity, along with infectious and inflammatory conditions (e.g., sexually transmitted infections and genitourinary tuberculosis), further contribute to the regional burden. Genetic etiologies are likely underdiagnosed due to limited diagnostic infrastructure. Methodological challenges, including variability in semen analysis standards, lack of harmonized laboratory practices, and incomplete surveillance systems, constrain robust epidemiological inference. Future multicenter studies integrating standardized World Health Organization protocols, exposure-stratified sampling, and comprehensive phenotyping – alongside efforts to establish population-based sampling frameworks – are essential to generate reliable prevalence estimates and inform targeted interventions in Central Asia.
- 1 July 2026
- Published by Wolters Kluwer Health in West Kazakhstan Regenerative Medicine Journal
- Vol. 14 (3) , 197-203
Open AccessMale Infertility in Central Asia: Epidemiology and Risk Factors from a Multicenter Study
A BSTRACT: Male infertility represents a substantial yet undercharacterized component of reproductive health in Central Asia, a region shaped by unique environmental exposures, heterogeneous healthcare systems, and evolving demographic patterns. Importantly, the current evidence base is predominantly derived from the clinic-based populations and should not be interpreted as reflecting population-level prevalence, which remains largely undefined across the region. This mini-review synthesizes the available evidence on the epidemiology and risk factors of male infertility across Kazakhstan, Uzbekistan, Kyrgyzstan, Tajikistan, and Turkmenistan, with a focus on multicenter cross-sectional research frameworks. Among clinic-based cohorts of infertile couples, male-factor infertility rates have been reported to reach up to 52.9%, although these estimates are influenced by care-seeking patterns, referral bias, and diagnostic variability. Environmental and occupational exposures – including particulate air pollution, pesticide residues, and dust–salt aerosols from the Aral Sea – emerge as biologically plausible contributors to impaired spermatogenesis. Lifestyle and metabolic factors such as smoking and obesity, along with infectious and inflammatory conditions (e.g., sexually transmitted infections and genitourinary tuberculosis), further contribute to the regional burden. Genetic etiologies are likely underdiagnosed due to limited diagnostic infrastructure. Methodological challenges, including variability in semen analysis standards, lack of harmonized laboratory practices, and incomplete surveillance systems, constrain robust epidemiological inference. Future multicenter studies integrating standardized World Health Organization protocols, exposure-stratified sampling, and comprehensive phenotyping – alongside efforts to establish population-based sampling frameworks – are essential to generate reliable prevalence estimates and inform targeted interventions in Central Asia.
- Open Access
- 1 July 2026
- Published by Wolters Kluwer Health in West Kazakhstan Regenerative Medicine Journal
- Vol. 14 (3) , 285-293
Artificial Intelligence and Multiomics in Urology: A Bibliometric Analysis of Male Reproductive Outcomes
A BSTRACT: Background: Research at the intersection of reproductive biology, omics technologies, and computational approaches has expanded rapidly, reflecting growing interest in precision medicine and data-driven biomedical research. Aims and Objectives: This study aimed to conduct a comprehensive bibliometric analysis to identify publication trends, influential contributors, collaboration patterns, and thematic evolution in this interdisciplinary field. Materials and Methods: Data were retrieved from the Web of Science Core Collection and analyzed using bibliometric tools and visualization techniques. Scientific production, leading countries, journals, authors, institutions, collaboration networks, keyword patterns, thematic maps, and research trends were evaluated. Results: Publication output increased markedly in recent years, with China and the United States leading in productivity and international collaboration. Key journals, authors, and institutions showed strong contributions to the field. Keyword and thematic analyses revealed a shift from traditional biological topics, including fertility and seminal plasma, toward integrative research involving genomics, proteomics, biomarker discovery, and computational methods. Proteomics was identified as a motor theme, while machine learning emerged as a highly relevant but still developing research area. Trend analysis also highlighted increasing attention to clinically oriented topics such as prostate cancer and male infertility. Conclusion: The findings demonstrate a clear transition toward interdisciplinary, translational, and data-driven research in reproductive biology. Integration of omics technologies, machine learning, and experimental biomedical approaches is likely to shape future advances in precision medicine and reproductive health.
- 1 July 2026
- Published by Wolters Kluwer Health in West Kazakhstan Regenerative Medicine Journal
- Vol. 14 (3) , 285-293
Open AccessArtificial Intelligence and Multiomics in Urology: A Bibliometric Analysis of Male Reproductive Outcomes
A BSTRACT: Background: Research at the intersection of reproductive biology, omics technologies, and computational approaches has expanded rapidly, reflecting growing interest in precision medicine and data-driven biomedical research. Aims and Objectives: This study aimed to conduct a comprehensive bibliometric analysis to identify publication trends, influential contributors, collaboration patterns, and thematic evolution in this interdisciplinary field. Materials and Methods: Data were retrieved from the Web of Science Core Collection and analyzed using bibliometric tools and visualization techniques. Scientific production, leading countries, journals, authors, institutions, collaboration networks, keyword patterns, thematic maps, and research trends were evaluated. Results: Publication output increased markedly in recent years, with China and the United States leading in productivity and international collaboration. Key journals, authors, and institutions showed strong contributions to the field. Keyword and thematic analyses revealed a shift from traditional biological topics, including fertility and seminal plasma, toward integrative research involving genomics, proteomics, biomarker discovery, and computational methods. Proteomics was identified as a motor theme, while machine learning emerged as a highly relevant but still developing research area. Trend analysis also highlighted increasing attention to clinically oriented topics such as prostate cancer and male infertility. Conclusion: The findings demonstrate a clear transition toward interdisciplinary, translational, and data-driven research in reproductive biology. Integration of omics technologies, machine learning, and experimental biomedical approaches is likely to shape future advances in precision medicine and reproductive health.
- Open Access
- 1 January 2026
- Published by Wolters Kluwer Health in West Kazakhstan Regenerative Medicine Journal
- Vol. 14 (1) , 67-76
Mapping Exosome-based Regenerative Urology: A Bibliometric Analysis of Trends and Future Directions
A BSTRACT: Introduction: Exosomes are considered as a promising cell-free approach in regenerative urology. Current research trends in the field of urinary tract restoration using exosome technologies are summarized. Objectives and Tasks: The goal is to conduct a bibliometric analysis of publications on exosomes in regenerative urology from 2021 to 2026 and identify the main thematic areas and development prospects for the field. Materials and Methods: A total of 276 publications for the given query were retrieved from the Web of Science Core Collection. The data was analyzed using Python (using pandas, matplotlib, seaborn, networkx, and other libraries) for quantitative and network analysis (authors, countries, keywords, thematic clusters). Results: The results reveal a steady increase in scientific output, with a notable surge after 2023, reflecting growing interest in cell-free therapeutic strategies. China emerged as the leading contributor in both publication volume and citation impact, supported by strong international collaborations. Keyword analysis identified exosomes, extracellular vesicles, and bladder cancer as dominant research themes, highlighting the central role of molecular mechanisms and translational applications. Thematic mapping demonstrated that cancer-related and extracellular vesicle research represent well-developed core areas, while emerging topics such as RNA-based biomarkers and diagnostic approaches indicate expanding research frontiers. Author-level analysis revealed a balance between high productivity and high-impact contributions, suggesting a distributed and collaborative research landscape. Conclusion: Overall, this study provides a systematic overview of exosome-based regenerative urology and offers valuable insights to guide future research and clinical translation.
- 1 January 2026
- Published by Wolters Kluwer Health in West Kazakhstan Regenerative Medicine Journal
- Vol. 14 (1) , 67-76
Open AccessMapping Exosome-based Regenerative Urology: A Bibliometric Analysis of Trends and Future Directions
A BSTRACT: Introduction: Exosomes are considered as a promising cell-free approach in regenerative urology. Current research trends in the field of urinary tract restoration using exosome technologies are summarized. Objectives and Tasks: The goal is to conduct a bibliometric analysis of publications on exosomes in regenerative urology from 2021 to 2026 and identify the main thematic areas and development prospects for the field. Materials and Methods: A total of 276 publications for the given query were retrieved from the Web of Science Core Collection. The data was analyzed using Python (using pandas, matplotlib, seaborn, networkx, and other libraries) for quantitative and network analysis (authors, countries, keywords, thematic clusters). Results: The results reveal a steady increase in scientific output, with a notable surge after 2023, reflecting growing interest in cell-free therapeutic strategies. China emerged as the leading contributor in both publication volume and citation impact, supported by strong international collaborations. Keyword analysis identified exosomes, extracellular vesicles, and bladder cancer as dominant research themes, highlighting the central role of molecular mechanisms and translational applications. Thematic mapping demonstrated that cancer-related and extracellular vesicle research represent well-developed core areas, while emerging topics such as RNA-based biomarkers and diagnostic approaches indicate expanding research frontiers. Author-level analysis revealed a balance between high productivity and high-impact contributions, suggesting a distributed and collaborative research landscape. Conclusion: Overall, this study provides a systematic overview of exosome-based regenerative urology and offers valuable insights to guide future research and clinical translation.
- Open Access
- 1 January 2026
- Published by Wolters Kluwer Health in West Kazakhstan Biomedicine Journal
- Vol. 7 (1) , 20-27
Oxidative Stress and Inflammatory Pathways in Male Infertility: Molecular Mechanisms and Therapeutic Strategies
A BSTRACT: Male infertility is increasingly recognized as a systems-level disorder where dysregulated redox homeostasis intersects with innate immune activation. Affecting approximately one in six individuals during their reproductive lifetime, male infertility is defined by the failure to conceive after 12 months of regular, unprotected intercourse. Oxidative stress, characterized by an excess of reactive oxygen species (ROS) relative to antioxidant defenses, impairs sperm function through lipid peroxidation, mitochondrial dysfunction, and DNA damage, while concurrently amplifying inflammatory signaling. Major ROS sources include sperm mitochondria, seminal leukocytes, NADPH oxidases (notably sperm NOX5), and oxidase systems linked to defective spermiogenesis. ROS activate redox-sensitive pathways, such as nuclear factor kappa B (NF-κB) and mitogen-activated protein kinases (MAPKs), as well as NLRP3 inflammasome signaling, establishing feed-forward loops that disrupt spermatogenesis, steroidogenesis, and sperm quality. Human and animal studies demonstrate associations between elevated seminal cytokine levels (interleukin-6, tumor necrosis factor-alpha, CXCL8), NOX5 upregulation, excess ROS, and DNA damage, as well as testicular NLRP3 activation in infection and toxin models. Therapeutically, broad antioxidant supplementation remains controversial; large randomized trials have shown no benefit and potential harm in unselected men, while meta-analyses suggest possible benefits with low certainty and high bias. Future progress likely depends on endotype-based patient selection using oxidative and inflammatory biomarkers, the development of pathway-specific interventions targeting NOX, NF-κB/MAPK, and NLRP3/caspase-1, and the refinement of assisted reproductive technology laboratory strategies to minimize iatrogenic oxidative injury.
- 1 January 2026
- Published by Wolters Kluwer Health in West Kazakhstan Biomedicine Journal
- Vol. 7 (1) , 20-27
Open AccessOxidative Stress and Inflammatory Pathways in Male Infertility: Molecular Mechanisms and Therapeutic Strategies
A BSTRACT: Male infertility is increasingly recognized as a systems-level disorder where dysregulated redox homeostasis intersects with innate immune activation. Affecting approximately one in six individuals during their reproductive lifetime, male infertility is defined by the failure to conceive after 12 months of regular, unprotected intercourse. Oxidative stress, characterized by an excess of reactive oxygen species (ROS) relative to antioxidant defenses, impairs sperm function through lipid peroxidation, mitochondrial dysfunction, and DNA damage, while concurrently amplifying inflammatory signaling. Major ROS sources include sperm mitochondria, seminal leukocytes, NADPH oxidases (notably sperm NOX5), and oxidase systems linked to defective spermiogenesis. ROS activate redox-sensitive pathways, such as nuclear factor kappa B (NF-κB) and mitogen-activated protein kinases (MAPKs), as well as NLRP3 inflammasome signaling, establishing feed-forward loops that disrupt spermatogenesis, steroidogenesis, and sperm quality. Human and animal studies demonstrate associations between elevated seminal cytokine levels (interleukin-6, tumor necrosis factor-alpha, CXCL8), NOX5 upregulation, excess ROS, and DNA damage, as well as testicular NLRP3 activation in infection and toxin models. Therapeutically, broad antioxidant supplementation remains controversial; large randomized trials have shown no benefit and potential harm in unselected men, while meta-analyses suggest possible benefits with low certainty and high bias. Future progress likely depends on endotype-based patient selection using oxidative and inflammatory biomarkers, the development of pathway-specific interventions targeting NOX, NF-κB/MAPK, and NLRP3/caspase-1, and the refinement of assisted reproductive technology laboratory strategies to minimize iatrogenic oxidative injury.
- Open Access
- 1 January 2026
- Published by Wolters Kluwer Health in West Kazakhstan Regenerative Medicine Journal
- Vol. 14 (1) , 3-8
Mesenchymal Stem Cell-derived Extracellular Vesicles for Male Infertility: Mechanisms and Potential
A BSTRACT: Male infertility contributes to nearly half of all infertility cases worldwide and arises from diverse etiologies, including oxidative stress, inflammation, endocrine disruption, and environmental exposures. Current treatment strategies, particularly assisted reproductive technologies, are often limited in their ability to restore normal spermatogenesis. Mesenchymal stem cell-derived extracellular vesicles (MSC-EVs) have emerged as a promising cell-free therapeutic approach in regenerative medicine. These vesicles carry a diverse cargo of proteins, lipids, and nucleic acids that can modulate cellular signaling pathways involved in testicular repair and spermatogenesis. This mini-review provides an overview of the biological characteristics of MSC-EVs, elaborates on their molecular mechanisms in male infertility, summarizes key findings from preclinical models, and discusses their translational potential and current challenges. MSC-EVs offer a novel therapeutic paradigm with improved safety and feasibility compared to stem cell-based therapies.
- 1 January 2026
- Published by Wolters Kluwer Health in West Kazakhstan Regenerative Medicine Journal
- Vol. 14 (1) , 3-8
Open AccessMesenchymal Stem Cell-derived Extracellular Vesicles for Male Infertility: Mechanisms and Potential
A BSTRACT: Male infertility contributes to nearly half of all infertility cases worldwide and arises from diverse etiologies, including oxidative stress, inflammation, endocrine disruption, and environmental exposures. Current treatment strategies, particularly assisted reproductive technologies, are often limited in their ability to restore normal spermatogenesis. Mesenchymal stem cell-derived extracellular vesicles (MSC-EVs) have emerged as a promising cell-free therapeutic approach in regenerative medicine. These vesicles carry a diverse cargo of proteins, lipids, and nucleic acids that can modulate cellular signaling pathways involved in testicular repair and spermatogenesis. This mini-review provides an overview of the biological characteristics of MSC-EVs, elaborates on their molecular mechanisms in male infertility, summarizes key findings from preclinical models, and discusses their translational potential and current challenges. MSC-EVs offer a novel therapeutic paradigm with improved safety and feasibility compared to stem cell-based therapies.
- Open Access
- 1 January 2026
- Published by Wolters Kluwer Health in West Kazakhstan Biomedicine Journal
- Vol. 7 (1) , 35-42
Global Research Trends in Sperm Quality and DNA Fragmentation Biomarkers: A Bibliometric Analysis
A BSTRACT: Introduction: Male infertility is a multifactorial pathological condition in which standard semen analysis does not always adequately predict reproductive outcomes. In recent years, particular attention has been paid to molecular markers of sperm quality, particularly sperm DNA fragmentation, which is considered one of the most promising biomarkers of reproductive potential. Study Objective: To conduct a bibliometric analysis of global research trends in sperm quality and sperm DNA fragmentation biomarkers in order to identify development trends, key research areas, and the structure of scientific collaborations. Materials and Methods: The study included 125 original research articles published between 2021 and 2026. The search was conducted in the Web of Science Core Collection database. Bibliometrix and Biblioshiny software tools, along with additional Python-based visualization methods, were used for bibliometric analysis. The analysis included an assessment of publication activity, citation impact, co-authorship networks, and topic modeling. Results: It was found that scientific productivity in this area demonstrates an overall upward trend, peaking in publication activity in 2025. However, the average citation rate tends to decrease, indicating a disconnect between the number of publications and their scientific impact. China, Italy, and Iran, characterized by high publication activity and a well-developed system of international collaboration, made the greatest contributions to the development of this field. An analysis of co-authorship revealed a fragmented structure of the research community. Key thematic areas identified include oxidative stress, sperm DNA fragmentation, apoptosis, and sperm quality. Thematic analysis revealed a shift in interest toward the mechanistic and translational aspects of male infertility. Conclusion: This study allows us to characterize the intellectual structure and evolution of research in the field of sperm biomarkers. The findings highlight the need to improve the scientific quality of research, strengthen international collaboration, and focus on clinically relevant areas to improve the diagnosis and treatment of male infertility.
- 1 January 2026
- Published by Wolters Kluwer Health in West Kazakhstan Biomedicine Journal
- Vol. 7 (1) , 35-42
Open AccessGlobal Research Trends in Sperm Quality and DNA Fragmentation Biomarkers: A Bibliometric Analysis
A BSTRACT: Introduction: Male infertility is a multifactorial pathological condition in which standard semen analysis does not always adequately predict reproductive outcomes. In recent years, particular attention has been paid to molecular markers of sperm quality, particularly sperm DNA fragmentation, which is considered one of the most promising biomarkers of reproductive potential. Study Objective: To conduct a bibliometric analysis of global research trends in sperm quality and sperm DNA fragmentation biomarkers in order to identify development trends, key research areas, and the structure of scientific collaborations. Materials and Methods: The study included 125 original research articles published between 2021 and 2026. The search was conducted in the Web of Science Core Collection database. Bibliometrix and Biblioshiny software tools, along with additional Python-based visualization methods, were used for bibliometric analysis. The analysis included an assessment of publication activity, citation impact, co-authorship networks, and topic modeling. Results: It was found that scientific productivity in this area demonstrates an overall upward trend, peaking in publication activity in 2025. However, the average citation rate tends to decrease, indicating a disconnect between the number of publications and their scientific impact. China, Italy, and Iran, characterized by high publication activity and a well-developed system of international collaboration, made the greatest contributions to the development of this field. An analysis of co-authorship revealed a fragmented structure of the research community. Key thematic areas identified include oxidative stress, sperm DNA fragmentation, apoptosis, and sperm quality. Thematic analysis revealed a shift in interest toward the mechanistic and translational aspects of male infertility. Conclusion: This study allows us to characterize the intellectual structure and evolution of research in the field of sperm biomarkers. The findings highlight the need to improve the scientific quality of research, strengthen international collaboration, and focus on clinically relevant areas to improve the diagnosis and treatment of male infertility.
- Open Access
- 19 December 2023
- Published by Springer Nature in Current Urology Reports
- Vol. 25 (1) , 37-47
Smart Diagnosis of Urinary Tract Infections: is Artificial Intelligence the Fast-Lane Solution?
Purpose of Review: Artificial intelligence (AI) can significantly improve physicians’ workflow when examining patients with UTI. However, most contemporary reviews are focused on examining the usage of AI with a restricted quantity of data, analyzing only a subset of AI algorithms, or performing narrative work without analyzing all dedicated studies. Given the preceding, the goal of this work was to conduct a mini-review to determine the current state of AI-based systems as a support in UTI diagnosis. Recent Findings: There are sufficient publications to comprehend the potential applications of artificial intelligence in the diagnosis of UTIs. Existing research in this field, in general, publishes performance metrics that are exemplary. However, upon closer inspection, many of the available publications are burdened with flaws associated with the improper use of artificial intelligence, such as the use of a small number of samples, their lack of heterogeneity, and the absence of external validation. AI-based models cannot be classified as full-fledged physician assistants in diagnosing UTIs due to the fact that these limitations and flaws represent only a portion of all potential obstacles. Instead, such studies should be evaluated as exploratory, with a focus on the importance of future work that complies with all rules governing the use of AI. Summary: AI algorithms have demonstrated their potential for UTI diagnosis. However, further studies utilizing large, heterogeneous, prospectively collected datasets, as well as external validations, are required to define the actual clinical workflow value of artificial intelligence.
- 19 December 2023
- Published by Springer Nature in Current Urology Reports
- Vol. 25 (1) , 37-47
Open AccessSmart Diagnosis of Urinary Tract Infections: is Artificial Intelligence the Fast-Lane Solution?
Purpose of Review: Artificial intelligence (AI) can significantly improve physicians’ workflow when examining patients with UTI. However, most contemporary reviews are focused on examining the usage of AI with a restricted quantity of data, analyzing only a subset of AI algorithms, or performing narrative work without analyzing all dedicated studies. Given the preceding, the goal of this work was to conduct a mini-review to determine the current state of AI-based systems as a support in UTI diagnosis. Recent Findings: There are sufficient publications to comprehend the potential applications of artificial intelligence in the diagnosis of UTIs. Existing research in this field, in general, publishes performance metrics that are exemplary. However, upon closer inspection, many of the available publications are burdened with flaws associated with the improper use of artificial intelligence, such as the use of a small number of samples, their lack of heterogeneity, and the absence of external validation. AI-based models cannot be classified as full-fledged physician assistants in diagnosing UTIs due to the fact that these limitations and flaws represent only a portion of all potential obstacles. Instead, such studies should be evaluated as exploratory, with a focus on the importance of future work that complies with all rules governing the use of AI. Summary: AI algorithms have demonstrated their potential for UTI diagnosis. However, further studies utilizing large, heterogeneous, prospectively collected datasets, as well as external validations, are required to define the actual clinical workflow value of artificial intelligence.
- Open Access
- 6 April 2021
- Published by Springer Nature in Stem Cell Research & Therapy
- Vol. 12 (1) , 1-12
Mesenchymal stromal/stem cells and their exosomes for restoration of spermatogenesis in non-obstructive azoospermia: a systemic review
Stem cells have been introduced as new promising therapeutic agents in treatment of degenerative diseases because of having high differentiation potential while maintaining the ability to self-replicate and retaining features of their source cells. Among different type of cell therapies, mesenchymal stromal/stem cell (MSC) therapy is being increasingly developed as a new way to treat structural defects that need to be repaired and regenerated. Non-obstructive azoospermia (NOA) is a reproductive disease in men that causes infertility in 10% of infertile men. Based on in vitro studies, MSCs from different tissue sources have been differentiated into germ cells or gamete progenitor cells by simple methods in both male and female. On the other hand, the therapeutic effects of MSCs have been evaluated for the treatment of NOA animal models created by chemical or surgical compounds. The results of these studies confirmed successful allotransplantation or xenotransplantation of MSCs in the seminiferous tubules. As well, it has been reported that exosomes secreted by MSCs are able to induce the process of spermatogenesis in the testes of infertile animal models. Despite numerous advances in the treatment of reproductive diseases in men and women with the help of MSCs or their exosomes, no clinical trial has been terminated on the treatment of NOA. This systematic review attempts to investigate the possibility of MSC therapy for NOA in men.
- 6 April 2021
- Published by Springer Nature in Stem Cell Research & Therapy
- Vol. 12 (1) , 1-12
Open AccessMesenchymal stromal/stem cells and their exosomes for restoration of spermatogenesis in non-obstructive azoospermia: a systemic review
Stem cells have been introduced as new promising therapeutic agents in treatment of degenerative diseases because of having high differentiation potential while maintaining the ability to self-replicate and retaining features of their source cells. Among different type of cell therapies, mesenchymal stromal/stem cell (MSC) therapy is being increasingly developed as a new way to treat structural defects that need to be repaired and regenerated. Non-obstructive azoospermia (NOA) is a reproductive disease in men that causes infertility in 10% of infertile men. Based on in vitro studies, MSCs from different tissue sources have been differentiated into germ cells or gamete progenitor cells by simple methods in both male and female. On the other hand, the therapeutic effects of MSCs have been evaluated for the treatment of NOA animal models created by chemical or surgical compounds. The results of these studies confirmed successful allotransplantation or xenotransplantation of MSCs in the seminiferous tubules. As well, it has been reported that exosomes secreted by MSCs are able to induce the process of spermatogenesis in the testes of infertile animal models. Despite numerous advances in the treatment of reproductive diseases in men and women with the help of MSCs or their exosomes, no clinical trial has been terminated on the treatment of NOA. This systematic review attempts to investigate the possibility of MSC therapy for NOA in men.